[HTML] nih.gov

[HTML][HTML] Protective effects of statins on limb and cardiovascular outcomes in patients with peripheral artery disease and end-stage renal disease

CR Lu, SY Lu, SY Lin, HT Yip, CH Liu… - Acta Cardiologica …, 2023 - ncbi.nlm.nih.gov
Background Previous studies have reported that statins have inconsistent and marginal
cardiovascular (CV) benefits in patients with end-stage renal disease (ESRD). However …
被引用次数：1 相关文章

Protective Effects of Statins on Limb and Cardiovascular Outcomes in Patients with Peripheral Artery Disease and End-Stage Renal Disease.

CR Lu, SY Lu, SY Lin, HT Yip, CH Liu… - Acta Cardiologica …, 2023 - europepmc.org
Background Previous studies have reported that statins have inconsistent and marginal
cardiovascular (CV) benefits in patients with end-stage renal disease (ESRD). However …

Protective Effects of Statins on Limb and Cardiovascular Outcomes in Patients with Peripheral Artery Disease and End-Stage Renal Disease

CR Lu, SY Lu, SY Lin, HT Yip, CH Liu… - Acta …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Previous studies have reported that statins have inconsistent and marginal
cardiovascular (CV) benefits in patients with end-stage renal disease (ESRD). However …

Protective Effects of Statins on Limb and Cardiovascular Outcomes in Patients with Peripheral Artery Disease and End-Stage Renal Disease

CR Lu, SY Lu, SY Lin, HT Yip, CH Liu… - Acta Cardiologica …, 2023 - airitilibrary.com
Background: Previous studies have reported that statins have inconsistent and marginal
cardiovascular (CV) benefits in patients with end-stage renal disease (ESRD). However …

[引用][C] Protective Effects of Statins on Limb and Cardiovascular Outcomes in Patients with Peripheral Artery Disease and End-Stage Renal Disease

CR Lu, SY Lu, SY Lin, HT Yip, CH Liu, KC Hsu… - europepmc.org
Background: Previous studies have reported that statins have inconsistent and marginal
cardiovascular (CV) benefits in patients with end-stage renal disease (ESRD). However …